Synthetic Haptens and Monoclonal Antibodies to the Cyanotoxin Anatoxin‐a

The authors declare no conflict of interest. The immunoreagents herein reported are available upon request for evaluation and research purposes. These developments have been patented (WO2017085339A1) and an exclusive license has been granted to Abraxis, Inc (Pennsylvannia, USA) for the production and commercialization of immunoanalytical methods for anatoxin-a.